Primary graft dysfunction after cardiac Transplantation: a prospective study on incidence, outcome and risk factors

Primary graft dysfunction after cardiac Transplantation: a prospective study on incidence, outcome and risk factors - PGD-Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021454

Enrollment

200

Registered

2020-12-02

Start date

2019-02-27

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PGD after HTX

Interventions

Group 1: 200 patients are to be included over a period of 2,5 years. The study will last 5 years in total. Study protocol: From every patient in our institution, undergoing cardiac transplantation for

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who have had a heart transplantation for the first time

Exclusion criteria

Exclusion criteria: Patients who have already had an allograft transplantation. Patients incapable of giving consent.

Design outcomes

Primary

Measure	Time frame
The occurrence of primary graft dysfunction after heart transplantation according to the ISHLT criteria.	—

Secondary

Measure	Time frame
In-hospital mortality, 30-day mortality, morbidity (apoplex, bleeding, GIT complications, liver and renal failure), infections / sepsis, rejection episodes, 1-year survival, re-thoracotomy	—

Countries

Germany

Contacts

Public ContactHeike Windhagen

Herz- u. Diabeteszentrum NRW Klinik für Thorax- u. Kardiovaskularchirurgie Studienabteilung Chirurgie

hwindhagen@hdz-nrw.de+49-5731-97-3135

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026